FDA label 7093b022-3673-4fc1-b51b-7bdb2ced1438
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)
- SPL set ID
- 03b33f5d-8c8e-4bdd-a5ae-9a7bb2f5e461
- SPL ID
- 7093b022-3673-4fc1-b51b-7bdb2ced1438
- Version
- 1
- Effective date
- 2016-04-08
- Source export date
- 2026-10-12
- Source partition
- 10
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0010-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-10-12/befa34274042a52f589b22fe2add0b1c6f0a385c96447c28303de164bb144af5/drug-label-0010-of-0014.json.zip
- Source manifest SHA-256
- 7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
- Import run
- 20261013T011858Z
- Imported at
- 2026-10-13 02:35:21
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
Harmonized identifiers page 1 of 1 · 2 matching rows.
Adverse reactions cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Adverse reactions sections page 1 of 1 · 2 matching rows.
adverse reactions
ADVERSE REACTIONS The following local adverse reactions have been reported with corticosteroid suppositories: 1. Burning 2. Itching 3. Irritation 4. Dryness 5. Folliculitis 6. Hypopigmentation 7. Allergic Contact Dermatitis 8. Secondary Infection
adverse reactions table
<table width="75%" styleCode="Noautorules"> <col width="50%" align="left" valign="top"/> <col width="50%" align="left" valign="top"/> <tbody> <tr> <td> <list listType="unordered"> <item> <caption>1.</caption>Burning</item> <item> <caption>2.</caption>Itching</item> <item> <caption>3.</caption>Irritation</item> <item> <caption>4.</caption>Dryness</item> </list> </td> <td> <list listType="unordered"> <item> <caption>5.</caption>Folliculitis</item> <item> <caption>6.</caption>Hypopigmentation</item> <item> <caption>7.</caption>Allergic Contact Dermatitis</item> <item> <caption>8.</caption>Secondary Infection</item> </list> </td> </tr> </tbody> </table>
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.